Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aimei Health Technology (AFJK) Gains from Investment Securities (2024 - 2025)

Aimei Health Technology (AFJK) has 2 years of Gains from Investment Securities data on record, last reported at -$482171.0 in Q3 2025.

  • On a quarterly basis, Gains from Investment Securities rose 48.9% to -$482171.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.4 million, a N/A change, with the full-year FY2024 number at -$3.6 million, down 1709.88% from a year prior.
  • Gains from Investment Securities reached -$482171.0 in Q3 2025 per AFJK's latest filing, down from -$466574.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for AFJK hit a ceiling of -$466574.0 in Q2 2025 and a floor of -$943529.0 in Q3 2024.